Search Results 71-80 of 22327 for neurofibromatosis
The purpose of this study is to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated ...
... neurofibromatosis type 1 (NF1). A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And ...
Neurofibromatosis Type 2 Clinic · Neurology · Neurosurgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Radiation Oncology ...
Neurofibromatosis 1. Mayo Clinic; 2021. Nimmagadda R. Allscripts EPSi. Mayo Clinic. Nov. 13, 2024. Medical review (expert opinion). Mayo Clinic. Nov. 16 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.